Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FAM19A4/miR124‐2 methylation in invasive cervical cancer: A retrospective cross‐sectional worldwide study

7 Aug 2019

Abstract excerpt

Widespread adoption of primary human papillomavirus (HPV)-based screening has encouraged the search for a triage test which retains high sensitivity for the detection of cervical cancer and precancer, but increases specificity to avoid overtreatment. Methylation analysis of FAM19A4 and miR124-2 genes has shown promise for the triage of high-risk (hr) HPV-positive women. In our study, we assessed the consistency...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related gene regulation
Share to Cervical Cancer and HPV Research
Share to Urinary and Genital Oncology Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31390052
DOI: 10.1002/ijc.32614

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FAM19A4/miR124‐2 methylation in invasive cervical cancer: A retrospective cross‐sectional worldwide studyPMID 31390052Read ↗

Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-up.Semantic proximity Read ↗

Performance of DNA methylation‐based biomarkers in the cervical cancer screening program of northern Portugal: A feasibility studySemantic proximity Read ↗

FAM19A4 and hsa-miR124-2 Double Methylation as Screening for ASC-H- and CIN1 HPV-Positive WomenSemantic proximity Read ↗

FAM19A4/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16/18 Genotyping in HPV-Positive Women Under the Age of 30 Years.Semantic proximity Read ↗

A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients.Semantic proximity Read ↗

Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women.Semantic proximity Read ↗

Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology-screened referral population.Semantic proximity Read ↗

Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3Semantic proximity Read ↗

Development of a multiplex methylation-specific PCR as candidate triage test for women with an HPV-positive cervical scrape.Semantic proximity Read ↗

Cervix cytology samples revealed increased methylation of the human markers FAM19A4 / miR124‐2 up to 8 years before adenocarcinomaSemantic proximity Read ↗

Tissue-based methylation testing as a predictor of clinical regression in patients with high- grade cervical intraepithelial neoplasia (CIN2/3)Semantic proximity Read ↗

CADM1 , MAL and miR124-2 methylation analysis in cervical scrapes to detect cervical and endometrial cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.